The Europe Iv Hydration Therapy Market is estimated to be valued at US$ 261.68 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Iv hydration therapy involves administering intravenous fluids to replenish fluids and minerals in the body. It is used to treat dehydration, hangovers, jet lag, and prepare for intense workout or sports activities. The fluids are administered through an IV line placed in a vein. Saline, vitamins and other minerals are used for iv hydration therapy. It provides fast acting hydration and helps to replenish lost electrolytes in the body. The therapy is gaining popularity among athletes, jet-setters and partygoers to recover quickly.
The key drivers fuelling growth of Europe iv hydration therapy market include rising health consciousness among consumers, growing consumption of alcohol and changing lifestyle. Consumers are increasingly opting for fast acting iv hydration therapy to treat dehydration and recover quickly from stressful activities like workouts, travelling or parties. The fast-paced lifestyle has also increased alcohol consumption which causes dehydration in the body. Moreover, growing adoption of wellness programs and campaigns to maintain health and fitness is supporting demand for hydration therapy services in the region. However, lack of awareness about therapy benefits in some parts of Europe and high treatment costs are some challenges for market growth.
The Europe IV hydration therapy market is segmented into clinics, hospitals and homecare settings. The clinics segment currently dominates the market owing to the increasing numbers of IV hydration clinics across major countries in Europe. These clinics offer services without any hassle or wait time and are majorly preferred by individuals seeking hangover cure or general hydration.
Political: The market is positively impacted by supportive government policies and initiatives focused on preventive healthcare. For instance, the UK government promotes hydration therapy to reduce burden on NHS.
Economic: Rising disposable incomes and growing health awareness is augmenting the demand for wellness services like IV hydration therapy among consumers in Europe.
Social: Changing lifestyles with increased alcohol consumption and long working hours contributes to the growth of dehydration cases, driving the need for IV therapy services.
Technological: Advancements in intravenous equipment and solutions aid healthcare professionals to infuse medications and fluids more effectively. This improves treatment outcomes.
The Europe Iv Hydration Therapy Market Share is expected to witness high growth, exhibiting CAGR of 7.2% over the forecast period of 2023 to 2030, due to increasing incidence of chronic diseases requiring IV therapies.
Regional analysis: United Kingdom holds the largest share in the regional market owing to significant awareness initiatives by local governments as well as presence of global key players. Spain is estimated to register fastest growth on the back of growing medical tourism industry in the country.
Key players: Key players operating in the Europe Iv Hydration Therapy Market are REVITA, Ivtherapygreece, IV Boost UK, Harpal Clinic Limited, IV Drips London, VITAMIN INJECTIONS LONDON, Cryojuvenate UK Ltd., Italy Health Retreats, SÃ©choir, ELIXIR, Swiss Medical Centre, Drip Hydration, REVIV, VITANOVAS, and The IV Doc Inc. REVITA leads the market with a wide regional presence and effective marketing strategies to promote its hydration therapy programs.